Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
João Mauricio Castaldelli-Maia, Victoria Camargos de Oliveira, Flávia Mariana Irber, Israel K. Blaas, Bernard Angerville, Anderson Sousa Martins-da-Silva, Gislaine Koch Gimenes, Marcela Waisman Campos, Julio Torales, Antonio Ventriglio, Carine Guillois, Houria El Ouazzani, Léna Gazaix, Pascal Favré, Alain Dervaux & Gisèle Apter. (2023) Psychopharmacology of smoking cessation medications: focus on patients with mental health disorders. International Review of Psychiatry 0:0, pages 1-21.
Read now
Read now
Nikki Bozinoff & Bernard Le Foll. (2018) Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment. Expert Review of Respiratory Medicine 12:9, pages 793-804.
Read now
Read now
Melissa A. Little & Jon O. Ebbert. (2016) The safety of treatments for tobacco use disorder. Expert Opinion on Drug Safety 15:3, pages 333-341.
Read now
Read now
Articles from other publishers (26)
Omar Soler-Cedeno & Zheng-Xiong Xi. (2022) Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge. Cells 11:20, pages 3262.
Crossref
Crossref
Ana Domi, Veronica Lunerti, Michele Petrella, Esi Domi, Anna Maria Borruto, Massimo Ubaldi, Friedbert Weiss & Roberto Ciccocioppo. (2022) Genetic deletion or pharmacological blockade of nociceptin/orphanin FQ receptors in the ventral tegmental area attenuates nicotine‐motivated behaviour. British Journal of Pharmacology 179:11, pages 2647-2658.
Crossref
Crossref
Stefan Andreas, Anil Batra, Dörthe Brüggmann, Dieter Geyer, Helmut Gohlke, Thomas Hering, Andreas Jähne, Julia Jückstock, Marianne Klein, Daniel Kotz, Christoph Kröger, Timo Krüger, Michael Kölch, Evelyn Lesta, Johannes Lindenmeyer, Peter Lindinger, Ute Mons, Stephan Mühlig, Tim Neumann, Kay Uwe Petersen, Thomas Polak, Ulrich W. Preuss, Martina Pötschke-Langer, Christa Rustler, Tobias Rüther, Sophie Luise Schiller, Christiane Schwarz, Cornelie Schweizer, Rainer Thomasius, Sabina Ulbricht & Clemens Veltrup. 2022. S3-Leitlinie Rauchen und Tabakabhängigkeit: Screening, Diagnostik und Behandlung. S3-Leitlinie Rauchen und Tabakabhängigkeit: Screening, Diagnostik und Behandlung
41
171
.
Briana DiSilvio, Mohammad Baqdunes, Ahmad Alhajhusain & Tariq Cheema. (2021) Smoking Addiction and Strategies for Cessation. Critical Care Nursing Quarterly 44:1, pages 33-48.
Crossref
Crossref
Zheng‐Xiong Xi, Pretal Muldoon, Xiao‐Fei Wang, Guo‐Hua Bi, M. Imad Damaj, Aron H. Lichtman, Roger G. Pertwee & Eliot L. Gardner. (2019)
Δ
8
‐Tetrahydrocannabivarin has potent anti‐nicotine effects in several rodent models of nicotine dependence
. British Journal of Pharmacology 176:24, pages 4773-4784.
Crossref
Crossref
A. Wojtczyk-Miaskowska & B. Schlichtholz. (2019) Tobacco carcinogens and the methionine metabolism in human bladder cancer. Mutation Research/Reviews in Mutation Research 782, pages 108281.
Crossref
Crossref
Ewa Galaj & Zheng-Xiong Xi. (2019) Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders. CNS Drugs.
Crossref
Crossref
Marie N. S. Gendy, Christine Ibrahim, Matthew E. Sloan & Bernard Le Foll. 2020. Substance Use Disorders. Substance Use Disorders
395
420
.
Frances R. Levin, C. Jean Choi, Martina Pavlicova, John J. Mariani, Amy Mahony, Daniel J. Brooks, Edward V. Nunes & John Grabowski. (2018) How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysis. Drug and Alcohol Dependence 188, pages 135-140.
Crossref
Crossref
Anton Schmick, Josef Jenewein & Sönke Böttger. (2018) Diagnose, Differentialdiagnose und Behandlung von Abhängigkeitserkrankungen im Allgemeinkrankenhaus (allgemeiner Teil)Diagnosis, differential diagnosis and therapy of substance use disorders in general hospital (general section). neuropsychiatrie 32:2, pages 57-68.
Crossref
Crossref
Alexios Politis, Vasileios Ioannidis, Konstantinos I Gourgoulianis, Zoe Daniil & Chrissi Hatzoglou. (2017) Effects of varenicline therapy in combination with advanced behavioral support on smoking cessation and quality of life in inpatients with acute exacerbation of COPD, bronchial asthma, or community-acquired pneumonia: A prospective, open-label, preference-based, 52-week, follow-up trial. Chronic Respiratory Disease 15:2, pages 146-156.
Crossref
Crossref
Mohammed Akbar, Mark Egli, Young-Eun Cho, Byoung-Joon Song & Antonio Noronha. (2018) Medications for alcohol use disorders: An overview. Pharmacology & Therapeutics 185, pages 64-85.
Crossref
Crossref
Nieves Gómez-Coronado, Adam J. Walker, Michael Berk & Seetal Dodd. (2018) Current and Emerging Pharmacotherapies for Cessation of Tobacco Smoking. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38:2, pages 235-258.
Crossref
Crossref
Rajnish Kumar,Ramandeep Kaur,Lalita Dahiya,Manoj Kumar. 2018. Vicinal Diaryl Substituted Heterocycles. Vicinal Diaryl Substituted Heterocycles
161
189
.
Mahesh A. Barmade & Rahul B. Ghuge. 2018. Vicinal Diaryl Substituted Heterocycles. Vicinal Diaryl Substituted Heterocycles
1
20
.
Changxi Zhou, Lei Wu, Qinghui Liu, Huaijie An, Bin Jiang, Fan Zuo, Li Zhang & Yao He. (2017) Evaluation of smoking cessation intervention in patients with chronic diseases in smoking cessation clinics. Medicine 96:42, pages e7459.
Crossref
Crossref
Menglu Yuan, Ariana M. Malagon, Dennis Yasuda, James D. Belluzzi, Frances M. Leslie & Nurulain T. Zaveri. (2017) The α3β4 nAChR partial agonist AT-1001 attenuates stress-induced reinstatement of nicotine seeking in a rat model of relapse and induces minimal withdrawal in dependent rats. Behavioural Brain Research 333, pages 251-257.
Crossref
Crossref
Matthew L. Banks. (2016) Utility of preclinical drug versus food choice procedures to evaluate candidate medications for methamphetamine use disorder. Annals of the New York Academy of Sciences 1394:1, pages 92-105.
Crossref
Crossref
C. J. Perry & A. J. Lawrence. (2017) Addiction, cognitive decline and therapy: seeking ways to escape a vicious cycle. Genes, Brain and Behavior 16:1, pages 205-218.
Crossref
Crossref
M. Shoaib & F.S. Hall. 2017. Negative Affective States and Cognitive Impairments in Nicotine Dependence. Negative Affective States and Cognitive Impairments in Nicotine Dependence
37
52
.
Julia Steinberger, Stephen R. Daniels, Nancy Hagberg, Carmen R. Isasi, Aaron S. Kelly, Donald Lloyd-Jones, Russell R. Pate, Charlotte Pratt, Christina M. Shay, Jeffrey A. Towbin, Elaine Urbina, Linda V. Van Horn & Justin P. Zachariah. (2016) Cardiovascular Health Promotion in Children: Challenges and Opportunities for 2020 and Beyond: A Scientific Statement From the American Heart Association. Circulation 134:12.
Crossref
Crossref
F. Scott Hall, Andre Der-Avakian, Thomas J. Gould, Athina Markou, Mohammed Shoaib & Jared W. Young. (2015) Negative affective states and cognitive impairments in nicotine dependence. Neuroscience & Biobehavioral Reviews 58, pages 168-185.
Crossref
Crossref
Megan M. Yardley, Michael M. Mirbaba & Lara A. Ray. (2015) Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers. CNS Drugs 29:10, pages 833-845.
Crossref
Crossref
Comfort A. Boateng, Oluyomi M. Bakare, Jia Zhan, Ashwini K. Banala, Caitlin Burzynski, Elie Pommier, Thomas M. Keck, Prashant Donthamsetti, Jonathan A. Javitch, Rana Rais, Barbara S. Slusher, Zheng-Xiong Xi & Amy Hauck Newman. (2015)
High Affinity Dopamine D
3
Receptor (D
3
R)-Selective Antagonists Attenuate Heroin Self-Administration in Wild-Type but not D
3
R Knockout Mice
. Journal of Medicinal Chemistry 58:15, pages 6195-6213.
Crossref
Crossref
Thomas M. Keck, Ashwini K. Banala, Rachel D. Slack, Caitlin Burzynski, Alessandro Bonifazi, Oluyomi M. Okunola-Bakare, Martin Moore, Jeffrey R. Deschamps, Rana Rais, Barbara S. Slusher & Amy Hauck Newman. (2015) Using click chemistry toward novel 1,2,3-triazole-linked dopamine D3 receptor ligands. Bioorganic & Medicinal Chemistry 23:14, pages 4000-4012.
Crossref
Crossref
Yu. V. Vakhitova, E. I. Farafontova, L. F. Zainullina, V. A. Vakhitov, I. P. Tsypysheva & M. S. Yunusov. (2015) Search for (-)-cytisine derivatives as potential inhibitors of NF-κB and STAT1. Russian Journal of Bioorganic Chemistry 41:3, pages 297-304.
Crossref
Crossref